v3.21.2

Potentially Dilutive Securities | 9 Months Ended
--- | ---
Sep. 30, 2021
Potentially Dilutive Securities |
Potentially Dilutive Securities | Note 4. Potentially Dilutive Securities The table below presents the computation of basic and diluted net loss per share of Common Stock: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three months ended | ​ | Nine months ended
​ | ​ | September 30, | ​ | September 30,
​ |  | 2021 |  | 2020 |  | 2021 |  | 2020
Basic numerator: |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |
Net income (loss) attributable to XpresSpa Group, Inc. | ​ | $ | 5,597 | ​ | $ | (6,110) | ​ | $ | 74 | ​ | $ | (74,805)
Less: deemed dividend on warrants and preferred stock | ​ |  | — | ​ |  | — | ​ |  | — | ​ |  | (945)
Net income (loss) attributable to common shareholders | ​ | $ | 5,597 | ​ | $ | (6,110) | ​ | $ | 74 | ​ | $ | (75,750)
Basic denominator: | ​ |  | ​ | ​ |  |  | ​ |  | ​ | ​ |  |
Basic weighted average shares outstanding | ​ |  | 105,531,418 | ​ |  | 61,106,894 | ​ |  | 103,950,731 | ​ |  | 35,309,004
Basic income (loss) per share | ​ | $ | 0.05 | ​ | $ | (0.10) | ​ | $ | — | ​ | $ | (2.15)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Diluted numerator: | ​ |  | ​ | ​ |  |  | ​ |  | ​ | ​ |  |
Net income (loss) attributable to common shareholders | ​ | $ | 5,597 | ​ | $ | (6,110) | ​ | $ | 74 | ​ | $ | (75,750)
Diluted denominator: | ​ |  | ​ | ​ |  |  | ​ |  | ​ | ​ |  |
Diluted weighted average shares outstanding | ​ |  | 105,957,317 | ​ |  | 61,106,894 | ​ |  | 104,301,344 | ​ |  | 35,309,004
Diluted net income (loss) per share | ​ | $ | 0.05 | ​ | $ | (0.10) | ​ | $ | — | ​ | $ | (2.15)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net income (loss) per share data presented above excludes from the calculation of diluted net income (loss) the following potentially dilutive securities, having an anti-dilutive impact. | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Both vested and unvested options to purchase an equal number of shares of Common Stock | ​ |  | 2,606,771 | ​ |  | 706,073 | ​ |  | 2,631,246 | ​ |  | 706,073
Unvested RSUs to issue an equal number of shares of Common Stock | ​ |  | 821,361 | ​ |  | — | ​ |  | 876,131 | ​ |  | —
Warrants to purchase an equal number of shares of Common Stock | ​ |  | 37,907,794 | ​ |  | 20,818,889 | ​ |  | 37,903,835 | ​ |  | 20,818,889
Convertible notes on an as converted basis | ​ |  | — | ​ |  | 438,017 | ​ |  | — | ​ |  | 438,017
Total number of potentially dilutive securities excluded from the calculation of loss per share attributable to common shareholders | ​ |  | 41,335,926 | ​ |  | 21,962,979 | ​ |  | 41,411,212 | ​ |  | 21,962,979
​

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareBasicAndDilutedAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for potentially dilutive securities. + References No definition available. + Details
Name: | xspa_PotentiallyDilutiveSecuritiesTextBlock
Namespace Prefix: | xspa_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration